Is Lexaria Bioscience Corp. (LEXX) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Armistice Capital Steven Boyd | 1,020,000 | $2,835,600 | 0.03% | |
2. | Invenomic Capital Management Ali Motamed | 513,573 | $1,427,733 | +9% | 0.06% |
3. | Renaissance Technologies Jim Simons | 22,800 | $63,384 | 0% | |
4. | ADAR1 Capital Management Daniel Schneeberger | 945 | $2,627 | -97% | 0% |
5. | Citadel Investment Group Ken Griffin | 0 | $0 | -100% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$3.13 | 1,600 | Director | 3,100 | 2024-08-12 | Filing | |
$2.84 | 1,500 | Director | 1,500 | 2023-02-09 | Filing | |
$2.09 | 121 | Officer | 1,954 | 2022-10-14 | Filing | |
$2.10 | 16,600 | Officer, Director | 254,412 | 2022-10-13 | Filing | |
$1.99 | 21,900 | Officer, Director | 237,812 | 2022-10-12 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$4.00 | 2,567 | Officer | 0 | 2024-07-31 | Filing | |
$1.90 | 2,100 | Director | 285,738 | 2018-05-31 | Filing | |
$1.91 | 100 | Director | 287,838 | 2018-05-30 | Filing | |
$1.90 | 47,800 | Director | 287,938 | 2018-05-30 | Filing | |
$0.35 | 700 | Officer | 250,385 | 2010-12-22 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 256,327 | $320,408 | 0.02% | |
2. | 78,950 | $98,688 | 0% | |
3. | 53,592 | $67,028 | 0% | |
4. | 46,241 | $57,801 | 0% | |
5. | 41,651 | $18,743 | 0.03% |